SLC5A2 and Obesity: As mice in both of the aforementioned obesity studies [20,21] were treated with SGLT2 inhibitors for a longer time than the BPH/2J mice were in our study, we hypothesize that extending our time course of treatment may potentially also enhance the beneficial effects of Dapagliflozin.